Andrew M. Stern

7.1k total citations · 1 hit paper
89 papers, 3.3k citations indexed

About

Andrew M. Stern is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Andrew M. Stern has authored 89 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 16 papers in Oncology and 11 papers in Hematology. Recurrent topics in Andrew M. Stern's work include Cancer-related gene regulation (9 papers), Platelet Disorders and Treatments (8 papers) and Blood properties and coagulation (8 papers). Andrew M. Stern is often cited by papers focused on Cancer-related gene regulation (9 papers), Platelet Disorders and Treatments (8 papers) and Blood properties and coagulation (8 papers). Andrew M. Stern collaborates with scholars based in United States, Germany and China. Andrew M. Stern's co-authors include David S. Sigman, Daniel R. Graham, Paul A. Friedman, Stuart L. Schreiber, William J. VanDusen, D. Lansing Taylor, Alykhan F. Shamji, J Martinéz, Drew Adams and Carl Barsigian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Andrew M. Stern

88 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxygen-dependent cleavage of DNA by the 1,10-phenanthroline . cuprous complex. Inhibition of Escherichia coli DNA polymerase I.

1979 476 citations Andrew M. Stern et al. profile →

Peers

Countries citing papers authored by Andrew M. Stern

Since Specialization

Citations

This map shows the geographic impact of Andrew M. Stern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Stern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Stern more than expected).

Fields of papers citing papers by Andrew M. Stern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew M. Stern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Stern. The network helps show where Andrew M. Stern may publish in the future.

Co-authorship network of co-authors of Andrew M. Stern

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Stern. A scholar is included among the top collaborators of Andrew M. Stern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Stern. Andrew M. Stern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy 2024 ·Frontiers in Cell and Developmental Biology ·(unknown), (unknown), (unknown), (unknown), Richard DeBiasio, (unknown), (unknown), Rodrigo M. Florentino, (unknown), Jacquelyn A. Brown, Lawrence A. Vernetti, Mark E. Schurdak, Andrew M. Stern, Albert Gough, Jaideep Behari, Alejandro Soto–Gutiérrez, D. Lansing Taylor, Mark T. Miedel	7
2	A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system 2024 ·Communications Biology ·Julio Aleman, K. Ravikumar, (unknown), Mark E. Schurdak, Lawrence A. Vernetti, (unknown), (unknown), Richard DeBiasio, (unknown), (unknown), Albert Gough, Alejandro Soto–Gutiérrez, Jaideep Behari, Vijay Yechoor, Mark T. Miedel, Andrew M. Stern, Ipsita Banerjee, D. Lansing Taylor	5
3	CellTrackVis: Analyzing the Performance of Cell Tracking Algorithms 2022 ·PubMed ·Weizi Li, (unknown), Andrew M. Stern, Marc R. Birtwistle, Federico Iuricich	2
4	A high-tech, low-cost, Internet of Things surfboard fin for coastal citizen science, outreach, and education 2022 ·Continental Shelf Research ·Philip J. Bresnahan, Tyler Cyronak, Robert J. W. Brewin, Andreas J. Andersson, (unknown), Todd R. Martz, Travis A. Courtney, (unknown), Ryan Kastner, Andrew M. Stern, (unknown), (unknown), (unknown), Katherine A. Green Hammond, (unknown)	10
5	Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance 2020 ·Molecular Cancer Research ·Esther P. Jane, Daniel R. Premkumar, (unknown), Brian Golbourn, Sameer Agnihotri, Kelsey C. Bertrand, Stephen C. Mack, (unknown), Ansuman Chattopadhyay, D. Lansing Taylor, Mark E. Schurdak, Andrew M. Stern, Ian F. Pollack	13
6	Human biomimetic liver microphysiology systems in drug development and precision medicine 2020 ·Nature Reviews Gastroenterology & Hepatology ·Albert Gough, Alejandro Soto–Gutiérrez, Lawrence A. Vernetti, Mo R. Ebrahimkhani, Andrew M. Stern, D. Lansing Taylor	85
7	Modeling the Effect of the Metastatic Microenvironment on Phenotypes Conferred by Estrogen Receptor Mutations Using a Human Liver Microphysiological System 2019 ·Scientific Reports ·Mark T. Miedel, (unknown), (unknown), Albert Gough, D. Lansing Taylor, Andrew M. Stern	17
8	Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable Phenotypes 2018 ·Oncology ·(unknown), Mark T. Miedel, (unknown), (unknown), Ning Chen, Peilu Wang, Amir Bahreini, Zheqi Li, Zhijie Ding, Tong Ying Shun, Daniel M. Zuckerman, D. Lansing Taylor, Shannon L. Puhalla, Adrian V. Lee, Steffi Oesterreich, Andrew M. Stern	14
9	Platform for Quantitative Evaluation of Spatial Intratumoral Heterogeneity in Multiplexed Fluorescence Images 2017 ·Cancer Research ·(unknown), Yousef Al‐Kofahi, (unknown), Timothy R. Lezon, Albert Gough, Andrew M. Stern, Adrian V. Lee, Fiona Ginty, Brion Sarachan, D. Lansing Taylor, (unknown)	12
10	Engineering a Smartfin for surf-zone oceanography 2017 ·Philip J. Bresnahan, Tyler Cyronak, Todd R. Martz, Andreas J. Andersson, (unknown), Andrew M. Stern, (unknown), Katherine A. Green Hammond, John N. Griffin, Benjamin S. Thompson	6
11	Pointwise mutual information quantifies intratumor heterogeneity in tissue sections labeled with multiple fluorescent biomarkers 2016 ·Journal of Pathology Informatics ·(unknown), Rekha Gyanchandani, Yousef Al‐Kofahi, Andrew M. Stern, Timothy R. Lezon, Albert Gough, Dan E. Meyer, Fiona Ginty, Brion Sarachan, Jeffrey L. Fine, Adrian V. Lee, D. Lansing Taylor, (unknown)	16
12	Treating gynecologic malignancies with selective estrogen receptor downregulators (SERDs): promise and challenges 2015 ·Molecular and Cellular Endocrinology ·M.M. Boisen, Courtney L. Andersen, Sreeja Sreekumar, Andrew M. Stern, Steffi Oesterreich	8
13	Rho Kinase Regulates the Survival and Transformation of Cells Bearing Oncogenic Forms of KIT, FLT3, and BCR-ABL 2011 ·Cancer Cell ·Raghuveer Singh Mali, Baskar Ramdas, Peilin Ma, Jianjian Shi, Veerendra Munugalavadla, Emily Sims, Lei Wei, Sasidhar Vemula, Sarah C. Nabinger, Charles B. Goodwin, Rebecca J. Chan, Fabı́ola Traina, Valeria Visconte, Ramón V. Tiu, Timothy A. Lewis, Andrew M. Stern, Qiang Wen, John D. Crispino, H. Scott Boswell, Reuben Kapur	79
14	Gene-environment interaction analysis of serotonin system markers with adolescent depression 2002 ·American Journal of Medical Genetics Part A ·Thalia C. Eley, Karen Sugden, Alice M. Gregory, Andrew M. Stern, Robert Plomin, Ian Craig	3
15	Influence of a Natural and a Synthetic Inhibitor of Factor XIIIa on Fibrin Clot Rheology 1999 ·Biophysical Journal ·(unknown), Lyle F. Mockros, Andrew M. Stern, L. Lóránd	65
16	Development of a Carbon Dioxide-Capture Assay in Microtiter Plate for Aspartyl-β-hydroxylase 1999 ·Analytical Biochemistry ·Ji-Hu Zhang, (unknown), (unknown), Thomas D.Y. Chung, Andrew M. Stern, Gregory Hollis, Robert A. Copeland, Kevin R. Oldenburg	15
17	The five cysteine residues located in the active site region of bovine aspartyl (asparaginyl) β-hydroxylase are not essential for catalysis 1998 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Kathleen A. McGinnis, (unknown), (unknown), Andrew M. Stern, Paul A. Friedman	4
18	Novel Inhibitors Against the Transglutaminase-catalysed Crosslinking of Lens Proteins 1998 ·Experimental Eye Research ·L. Lóránd, Andrew M. Stern, Pauline T. Velasco	18
19	Alendronate inhibition of protein-tyrosine-phosphatase-meg1 1997 ·Biochemical Pharmacology ·Evan E. Opas, Su Jane Rutledge, Ellis E. Golub, Andrew M. Stern, (unknown), Gideon A. Rodan, Azriel Schmidt	27
20	Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. 1996 ·Journal of Clinical Investigation ·(unknown), Steve Jia, Mitsuru Nishiyama, Suzanne de la Monte, Andrew M. Stern, Jack R. Wands, Paul A. Friedman	126

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact